Finance

Lists
Why is 042520 down 5,91%?
Dive Deeper
042520:KOSDAQ
HANS BIOMED CORP
15 290,00 ₩
-5,91%
(-960,00) 1D
6 նոյ, 15:30:30 GMT+9  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 042520...
Open
15 160 ₩
High
15 890 ₩
Low
15 000 ₩
Mkt. cap
218,06 մլրդ
Avg. vol.
115,67 հզր
Volume
118,59 հզր
52-wk high
57 800 ₩
52-wk low
14 630 ₩
EPS
-1 559 ₩
Shares outstanding
14,26 մլն
No. of employees
315
Open
15 160 ₩
High
15 890 ₩
Low
15 000 ₩
Mkt. cap
218,06 մլրդ
Avg. vol.
115,67 հզր
Volume
118,59 հզր
52-wk high
57 800 ₩
52-wk low
14 630 ₩
EPS
-1 559 ₩
Shares outstanding
14,26 մլն
No. of employees
315
News stories
From web sources and news partners
About HANS BIOMED CORP
CEOGuen Young Kim
Employees315
Founded1990
Headquarters-
SectorHealth Care
Industry-
Websitehansbiomed.com
Previous reportsAll values in KRW
Loading Previous Earnings...
Revenue
Net income
All values in KRW
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
23,71 մլրդ
30,27 մլրդ
34,49 մլրդ
36,35 մլրդ
Cost of goods sold
13,14 մլրդ
11,09 մլրդ
12,91 մլրդ
13,03 մլրդ
Cost of revenue
13,14 մլրդ
11,09 մլրդ
12,91 մլրդ
13,03 մլրդ
Research and development expenses
1,74 մլրդ
1,31 մլրդ
1,29 մլրդ
1,21 մլրդ
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
35,82 մլրդ
14,87 մլրդ
15,37 մլրդ
17,28 մլրդ
Operating expense
39,53 մլրդ
17,11 մլրդ
17,14 մլրդ
19,22 մլրդ
Total operating expenses
52,66 մլրդ
28,20 մլրդ
30,05 մլրդ
32,25 մլրդ
Operating income
-28,95 մլրդ
2,06 մլրդ
4,44 մլրդ
4,10 մլրդ
Other non operating income
7,63 մլն
279,50 մլն
-9,95 մլն
-9,09 մլն
EBT including unusual items
-26,59 մլրդ
2,17 մլրդ
4,21 մլրդ
2,03 մլրդ
EBT excluding unusual items
-26,59 մլրդ
2,17 մլրդ
4,21 մլրդ
2,03 մլրդ
Income tax expense
1,28 մլրդ
310,13 մլն
465,19 մլն
239,74 մլն
Effective tax rate
-4,82%
14,32%
11,05%
11,83%
Other operating expenses
-148,30 մլն
262,90 մլն
136,68 մլն
151,55 մլն
Net income
-27,62 մլրդ
2,06 մլրդ
3,96 մլրդ
1,93 մլրդ
Net profit margin
-116,45%
6,79%
11,49%
5,32%
Earnings per share
-
-
-
-
Interest and investment income
34,10 մլն
76,83 մլն
104,32 մլն
76,48 մլն
Interest expense
-462,26 մլն
-411,48 մլն
-453,28 մլն
-426,83 մլն
Net interest expenses
-428,17 մլն
-334,65 մլն
-348,96 մլն
-350,35 մլն
Depreciation and amortization charges
419,97 մլն
442,41 մլն
360,19 մլն
387,52 մլն
EBITDA
-27,75 մլրդ
3,22 մլրդ
5,54 մլրդ
5,20 մլրդ
Gain or loss from assets sale
-1,06 մլն
-1,00 հզր
-1,77 մլն
-594,00 հզր
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google Apps